🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the efficacy and safety of concu...
Status
Unknown
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2023-11-10
Trial ID
NCT06080854
Treatments Being Tested
This is a multicenter, open-label, phase Ib/II study of YL202 in combinatio...
Status
Recruiting
Location
Anhui Provincial Hospital(The First Affiliated Hospital of Ustc)
Start Date
2025-09-02
Trial ID
NCT07169994
This study is being conducted to explore the efficacy and safety of neoadju...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-05-01
Trial ID
NCT05827770
Treatments Being Tested
This study is aimed to evaluate the efficacy and safety of Sacituzumab Tiru...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07244874
Treatments Being Tested
This is an open-label, single-center, single-arm phase Ib clinical trial. T...
Status
Enrolling By Invitation
Location
Xiangya Hospital
Start Date
2025-07-10
Trial ID
NCT06882876
Treatments Being Tested
The SCIENCE trial is a multicenter, open-label, randomized, parallel, nonin...
Status
Not Yet Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2026-05-20
Trial ID
NCT07617389
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multi-center, phase...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2020-04-07
Trial ID
NCT04158440
Based on the preclinical rationale for combining surufatinib with immunothe...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2024-11-30
Trial ID
NCT06719700
The goal of this first-in-human, single-center, prospective, open-label, ph...
Status
Recruiting
Location
Department of Biotherapeutic, Chinese PLA General Hospital
Start Date
2023-02-23
Trial ID
NCT05699811
Treatments Being Tested
This study aims to investigate efficacy and safety of neoadjuvant toripalim...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-01-11
Trial ID
NCT06618014
Treatments Being Tested